 Product
Juvidex™
Licensee
Renovo Group plc
Indication
Scar improvement
Phase
Phase II
Description
Therapeutic formulation of the sugar mannose-6-phosphate designed for injection into newly formed wounds to promote healing with reduced scarring.
Return to Pipeline
|